Skip to main content
$0.085 -0.001 (-1.16%)

High

$0.09

Low

$0.09

Trades

15

Turnover

$18,591

Volume

214,739
30 June 2023 at 3:31pm
If you were already registered, log in here.

Short Interest

ASIC data, 14 Jun 2023

% Shorted

0.00% 0.16
vs 0.16% prior report

Most Shorted Rank

625th
of 711 shorted ASX stocks

Peak Short

0.31%
Sep 2020

Days to Cover

0.0
at 50d avg vol
Subject
OSX Ann: Appendix 3X

OSX Ann: Change to the Board of Directors

OSX Ann: Osteopore secures A$19m clinical-industrial partnership

OSX Ann: Osteopore Receives Approval for Hong Kong Sales

OSX Ann: Investor Presentation

OSX Ann: Osteopore granted patent in China opening local opportunity

OSX Ann: Activities Update Qtr Ending September 2021 and Appendix 4C

OSX Ann: Osteopore collaborates with Singular Health Group

OSX Ann: SHG: CSIRO Collaboration for AI-based Tool

OSX Ann: Appendix 3X and Appendix 3Zs

OSX Ann: Changes to Board of Directors

OSX Ann: Application for quotation of securities - OSX

OSX Ann: Notice of Release from Escrow

OSX Ann: Half Yearly Report and Accounts

OSX Ann: Osteopore Sponsors Australian Patient Trials

OSX Ann: Appendix 3X and Appendix 3Z

OSX Ann: Changes to Osteopore Board of Directors

OSX Ann: Activities Update Qtr Ending June 2021 and Appendix 4C

OSX Ann: Change in substantial holding

OSX Ann: Notification regarding unquoted securities - OSX

OSX Ann: Investor Presentation

OSX Ann: Results of Annual General Meeting

OSX Ann: AGM Teleconference Details

OSX Ann: Osteopore Expanded CE Listing

OSX Ann: Activities Update Qtr Ending March 2021 and Appendix 4C

OSX Ann: Notice of Annual General Meeting

OSX Ann: Osteopore Granted Patent for Smart 3D Biomimetic Scaffolds

OSX Ann: Annual General Meeting Date

OSX Ann: Appendix 4G and Corporate Governance Statement

OSX Ann: Annual Report to shareholders

OSX Ann: Investor Presentation

OSX Ann: Appendix 4E Preliminary Final Report

OSX Ann: Agreement with Terumo Blood and Cell Technologies

OSX Ann: Activities Update Qtr Ending December 2020 and Appendix 4C

OSX Ann: Change in substantial holding forms

OSX Ann: Investor Presentation

OSX Ann: Osteopore Signs Germany & Austria Distribution Agreement

OSX Ann: Updated Quarterly Activities Report

OSX Ann: OSX Appoints Ex-Resmed Finance Executive to CFO Position

OSX Ann: OSX Signs Australian & New Zealand Distribution Agreement

OSX Ann: Activities Update Qtr Ending September 2020 and Appendix 4C

If you were already registered, log in here.

Similar Companies

ANN
AVR
MGZ
NAN
NXS
PNV
SDI
SDI
S88
MAV
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS
MBM